SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pseudo Biologist who wrote (506)3/21/1997 5:46:00 PM
From: Brad C. Dunlap   of 1762
 
Hi Max, you are right on the money, anti-gp39 is the only product that will be using humanized ab. I heard today that the pre-industry clinicals have shown very strong evidence of efficacy for a multitude of autoimmune disorders. Lupus is the one disorder that seems to always come up in conversation. Believe it or not there is a national lupus foundation that claims that there are over 1,000,000 people in the US with Lupus. This is hard to believe but quite a substantial mkt.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News